图源:豆包随着2025年医保谈判日期的临近,不少药企开始筹划降价。在江苏省药品招采平台上最新一轮报价中,礼来生产的抗癌药塞普替尼胶囊从每盒3.28万元降至每盒1.86万元,降幅高达43%。礼来方面并没有明确回应塞普替尼今年是否参与谈判。负责该药中国市场推广的信达生物向健识局表示:此次塞普替尼属于正常范围的调价,并无特殊原因。塞普替尼是高选择性RET抑制剂,是2022年9月获批上市的。国内有一款同...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.